# Fecal Microbiota Transplant (FMT) in Melanoma Patients

> **NCT03341143** · PHASE2 · COMPLETED · sponsor: **Zarour, Hassane, MD** · enrollment: 20 (actual)

## Conditions studied

- Melanoma

## Interventions

- **DRUG:** Fecal Microbiota Transplant with Pembrolizumab

## Key facts

- **NCT ID:** NCT03341143
- **Lead sponsor:** Zarour, Hassane, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-19
- **Primary completion:** 2023-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03341143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03341143, "Fecal Microbiota Transplant (FMT) in Melanoma Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03341143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*